|
|
???tair.name??? >
???browser.page.title.author???
|
"liang ph"???jsp.browse.items-by-author.description???
Showing items 1-25 of 28 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-03-06 |
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
|
Tang, WF;Chang, YH;Lin, CC;Jheng, JR;Hsieh, CF;Chin, YF;Chang, TY;Lee, JC;Liang, PH;Lin, CY;Lin, GH;Cai, JY;Chen, YL;Chen, YS;Tsai, SK;Liu, PC;Yang, CM;Shadbahr, T;Tang, J;Hsu, YL;Huang, CH;Wang, LY;Chen, CC;Kau, JH;Hung, YJ;Lee, HY;Wang, WC;Tsai, HP;Horng, JT |
| 國家衛生研究院 |
2023-04-10 |
Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus
|
Chang, CC;Algaissi, A;Lai, CC;Chang, CK;Lin, JS;Wang, YS;Chang, BH;Chang, YC;Chen, WT;Fan, YQ;Peng, BH;Chao, CY;Tzeng, SR;Liang, PH;Sung, WC;Hu, AY;Chang, SC;Chang, MF |
| 中山醫學大學 |
2021 |
FUT8 Remodeling of EGFR Regulates Epidermal Keratinocyte Proliferation during Psoriasis Development
|
Kelel, M; Yang, RB; Tsai, TF; Liang, PH; Wu, FY; Huang, YT; Yang, MF; Hsiao, YP; Wang, LF; Tu, CF; Liu, FT; Lee, YLL |
| 中山醫學大學 |
2021 |
Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2
|
Kuo, CJ; Chao, TL; Kao, HC; Tsai, YM; Liu, YK; Wang, LHC; Hsieh, MC; Chang, SY; Liang, PH |
| 臺北醫學大學 |
2014 |
Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity
|
Jiang, PL;Lin, HJ;Wang, HW;Tsai, WY;Lin, SF;Chien, MY;Liang, PH;Huang, YY;Liu, DZ |
| 國家衛生研究院 |
2013-11 |
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors
|
Lin, TS;Liw, YW;Song, JS;Hsieh, TC;Yeh, HW;Hsu, LC;Lin, CJ;Wu, SH;Liang, PH |
| 臺北醫學大學 |
2013 |
Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization
|
Wang, HW;Jiang, PL;Lin, SF;Lin, HJ;Ou, KL;Deng, WP;Lee, LW;Huang, YY;Liang, PH;Liu, DZ |
| 臺北醫學大學 |
2013 |
Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization
|
Wang, HW;Jiang, PL;Lin, SF;Lin, HJ;Ou, KL;Deng, WP;Lee, LW;Huang, YY;Liang, PH;Liu, DZ |
| 臺北醫學大學 |
2013 |
Targeting the XIAP/caspase-7 complex selectively kills caspase-3 deficient malignancies
|
Lin, YF;Lai, TC;Chang, CK;Chen, CL;Huang, MS;Yang, CJ;Liu, HG;Dong, JJ;Chou, YA;Hsiao, M;Liang, PH |
| 國家衛生研究院 |
2008-08-01 |
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents
|
Kuo, CJ;Shie, JJ;Fang, JM;Yen, GR;Hsu, JTA;Liu, HG;Tseng, SN;Chang, SC;Lee, CY;Shih, SR;Liang, PH |
| 國家衛生研究院 |
2008-04-01 |
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71
|
Lee, JC; Shih, SR; Chang, TY; Tseng, HY; Shih, YF; Yen, KJ; Chen, WC; Shie, JJ; Fang, JM; Liang, PH; Chao, YS; Hsu, JTA |
| 國家衛生研究院 |
2008 |
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases
|
Kuo, CJ; Guo, RT; Lu, IL; Liu, HG; Wu, SY; Ko, TP; Wang, AHJ; Liang, PH |
| 國家衛生研究院 |
2007-11 |
Novel small-molecule inhibitors of transmissible gastroenteritis virus
|
Yang, CW; Yang, YN; Liang, PH; Chen, CM; Chen, WL; Chang, HY; Chao, YS; Lee, SJ |
| 國家衛生研究院 |
2007 |
Crystal structures and computer screened inhibitors of Helicobacter pylori undecaprenyl pyrophosphate synthase
|
Kuo, CJ;Guo, RT;Lu, IL;Liu, HG;Wu, SY;Ko, TP;Wang, AHJ;Liang, PH |
| 臺北醫學大學 |
2007 |
Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute
|
李慶國; Wen CC; Kuo YH; Jan JT; Liang PH; Wang SY; Liu HG; Lee CK; Chang ST; Kuo CJ; Lee SS; Hou CC; |
| 高雄醫學大學 |
2007 |
Pharmacophores and biological activities of SARS viral protease inhibitors
|
王惠民;梁博煌 ; Wang HM;Liang PH |
| 國家衛生研究院 |
2006-08-24 |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease
|
Lu, IL; Mahindroo, N; Liang, PH; Peng, YH; Kuo, CJ; Tsai, KC; Hsieh, HP; Chao, YS; Wu, SY |
| 國家衛生研究院 |
2006-06-15 |
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
|
Tsai, KC; Chen, SY; Liang, PH; Lu, IL; Mahindroo, N; Hsieh, HP; Chao, YS; Liu, L; Liu, D; Lien, W; Lin, TH; Wu, SY |
| 國立臺灣大學 |
2006-03 |
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease
|
Wu, CY; King, KY; Kuo, CJ; Fang, JM; Wu, YT; Ho, MY; Liao, CL; Shie, JJ; Liang, PH; Wong, CH |
| 國家衛生研究院 |
2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
|
Chen, CN; Lin, CPC; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH; Hsu, JTA |
| 國家衛生研究院 |
2004-12-10 |
One site mutation disrupts dimer formation in human DPP-IV proteins
|
Chien, CH; Huang, LH; Chou, CY; Chen, YS; Han, YS; Chang, GG; Liang, PH; Chen, X |
| 國家衛生研究院 |
2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
|
Hsu, JTA; Kuo, CJ; Hsieh, HP; Wang, YC; Huang, KK; Lin, CPC; Huang, PF; Chen, X; Liang, PH |
| 國家衛生研究院 |
2004-07-23 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate [Erratum: Biochemical and Biophysical Research Communications. 2004 Jun;318(4):862-867.]
|
Kuo, CJ; Chi, YH; Hsu, JTA; Liang, PH |
| 國立臺灣大學 |
2004-07 |
Small molecules targeting severe acute respiratory syndrome human coronavirus.
|
Wu, CY; Jan, JT; Ma, SH; Kuo, CJ; Juan, HF; Cheng, YS; Hsu, HH; Huang, HC; Wu, D; Brik, A; Liang, FS; Liu, RS; Fang, JM; Chen, ST; Liang, PH; Wong, CH |
| 國家衛生研究院 |
2004-06-11 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
|
Kuo, CJ; Chi, YH; Hsu, JTA; Liang, PH |
Showing items 1-25 of 28 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
